Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 20.82
-0.526 %
$ 843 M
Market Cap
48.42
P/E
Price Target
Average
--10.34%
Revenue Forecast
Estimate
8.43%
EBIT
Estimate
24.32%
Net Income
Estimate
253.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Phibro Animal Health Corporation
Wall Street analysts predict an average 1-year price target for PAHC of $18.7 , with forecasts ranging from
a
low of
$17 to a high of $21 .
PAHC Lowest Price Target
Wall Street Target
17 USD
-18.35%
PAHC Average Price Target
Wall Street Target
18.7 USD
-10.34%
PAHC Highest Price Target
Wall Street Target
21 USD
0.86%
REVENUE FORECAST
Revenue Forecast Chart PAHC
EBIT FORECAST
EBIT Forecast Chart PAHC
NET INCOME FORECAST
Net Income Chart PAHC